| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| White Richard Allen JR | SVP and Pres, Perf Chemicals | C/O INGEVITY CORPORATION, 4920 O'HEAR AVE, SUITE 400, NORTH CHARLESTON | Richard Allen White Jr. By: Mavis Huger as Attorney-in-Fact | 02 Mar 2026 | 0001902378 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | NGVT | Common Stock | Award | $0 | +1,204 | +5.7% | $0.000000 | 22,450 | 26 Feb 2026 | Direct | F1, F2 |
| transaction | NGVT | Common Stock | Award | $30,324 | -430 | -1.9% | $70.52 | 22,020 | 26 Feb 2026 | Direct | F3 |
| Id | Content |
|---|---|
| F1 | The Talent and Compensation Committee of the Company's board of directors certified the attainment of performance goals for certain performance-based restricted stock awards ("PSUs") effective February 26, 2026. The PSUs were settled with shares of common stock. |
| F2 | Includes (i) 94 shares of Common Stock purchased pursuant to the Amended and Restated 2017 Ingevity Corporation Employee Stock Purchase Plan, as amended ("ESPP") for the purchase period of July 1, 2025 to September 30, 2025 (the "September ESPP Shares"), and (ii) 76 shares of Common Stock purchased pursuant to the ESPP for the purchase period of October 1, 2025 to December 31, 2025 (the "December ESPP Shares"). In accordance with the terms of the ESPP, the September ESPP Shares were purchased at a price equal to 85% of the closing price of Issuer's Common Stock on July 1, 2025 and the December ESPP Shares were purchased at a price equal to 85% of the closing price of the Issuer's Common Stock on October 1, 2025. |
| F3 | Shares withheld by the Company to satisfy tax withholding obligations related to the PSUs that vested on February 26, 2026. |